Running title: RNAPII elongation rate and co-transcriptional splicing during [Keywords: RNAPII; transcription elongation rate; co-transcriptional splicing; kinetic coupling; mouse model, ESCs differentiation, neurons] Supplemental material is available for this article.
4 acting RNA sequences, as well as nascent RNA folding are influenced by the elongation rate of RNAPII (Eperon et al. 1988; Buratti and Baralle 2004; Saldi et al. 2018) . The global impact of RNAPII elongation rate in the regulation of AS was confirmed by perturbing RNAPII elongation with the use of drugs that inhibit Pol II elongation (Ip et al. 2011) . Exogenous agents also affect transcriptional coupling to AS. For instance, UV irradiation promotes RNAPII hyperphosphorylation with the subsequent inhibition of transcriptional elongation, leading to changes in AS, suggesting that transcriptional coupling to AS is a key feature of the DNA-damage response (Muñoz et al. 2009; Williamson et al. 2017) . So far, all studies in mammalian systems investigating the link between transcription elongation and AS have been confined to the use of cultured cells transfected with an α-amanitinresistant slow or fast elongating RNAPII. The consequences of this mechanism of regulation in vivo remain unexplored.
Here, we sought to address how does an altered transcriptional elongation rate affect gene expression and the control of AS? Secondly, what are the extent and the phenotypic consequences of the elongation control of AS? We generated mouse embryonic stem cells (ESCs) knocked-in for a slow RNAPII mutant allele (C4/R749H). We show that an appropriate RNAPII elongation rate is essential for proper mouse development. We observed that a reduced elongation rate results in major changes in splicing and in gene expression in pluripotent ESCs and along the pathway of neuronal differentiation. The impact of the kinetic coupling of RNAPII elongation rate with AS is more predominant in ESC-differentiated neurons than in pluripotent cells, as it is essential for the expression and splicing of neuron-specific genes involved in synapse signaling.
Results

Generation of slow RNAPII knock-in mutant mouse ES cells
To address the consequences of an altered transcriptional elongation rate for gene expression and for the kinetic control of AS, we set out to generate an in vivo model of a slow RNAPII by introducing a R749H mutation into the endogenous Pol2ra in mouse ESCs. This mutation is equivalent to the C4 point mutation identified in the Drosophila pol II largest subunit, which confers a lower elongation rate, is less capable of transcribing through natural elongation blocks, and causes non-lethal developmental defects in the heterozygous state (Coulter and Greenleaf 1985; Mortin et al. 1988; Chen et al. 1996) . The targeting in mouse ESCs was achieved by successive homologous recombination of constructs that contained a large portion of DNA encoding mouse RNAPII, including exon 14 harboring the R749H mutation ( Fig. 1 , henceforth referred to as WT/slow and slow/slow ESCs). We confirmed the correct targeting by Southern blotting (Supplementary Fig. 1a ) and Ion Torrent sequencing over a few kb region around the R749H mutation (data not shown). We verified the expression of mutant RNAPII in these cells by cDNA sequencing, a diagnostic XhoI digest (Fig. 1b,c) , and by allele-specific RT-qPCR ( Supplementary   Fig. 1b ).
Slow transcription elongation hinders early mouse development
The mutant ESCs were used to generate a slow RNAPII knock-in mouse model. First, we obtained mouse chimaeras from WT/slow ESCs clones; however, no germline transmission was observed following repeated attempts of breeding 8 chimeric male animals (data not shown). This indicates that ESCs with a heterozygous slow RNAPII are not able to contribute to gametogenesis. As an alternative approach, we set out to Maslon et al. 6 generate R749H mutant mice using CRISPR/Cas9 (Fig. 2a) . Specific single guide RNAs (sgRNAs) against Pol2ra were used for microinjection along with the Cas9 mRNA and a repair oligonucleotide template containing the R749H mutation ("slow oligo") and subsequently embryos were transferred into recipient mice at the two-cell stage. No live-borne mice were obtained containing homozygous or even heterozygous mutations in the Polr2a locus among the 47 pups (Supplementary Fig.   2 ). To rule out inefficient induction of double-strand DNA breaks (DSBs) by sgRNAs, we co-injected the same pair of sgRNAs with a repair template mixture containing a 1:1 ratio of a slow and a silent oligo, the latter being a repair template containing silent mutations. Again, we could not detect the slow mutation in any of the 51 pups born; however, we obtained two homozygotes and four heterozygotes through repair with silent oligo (Fig. 2b, Supplementary Fig. 2 ). Next, we investigated at what stage this mutation caused embryonic lethality. We microinjected slow oligo along with guide RNAs and analyzed the resulting embryos at the late morula/blastocyst stage. We found several slow heterozygous and 1 homozygous embryos, revealing that the R749H mutation was tolerated at the pre-implantation stage ( Fig. 2b, Supplementary Fig. 2 ). However, only one heterozygous and no homozygous slow mutations were found in mid-gestation embryos at E9.5-E11.5.
Thus, we conclude that the Polr2A R749H mutation causes early embryonic lethality.
The R749H mutation decreases the transcription elongation rate in mouse ESCs
We analyzed the effect of the slow RNAPII mutation in ESCs using 5,6-dichlorobenzimidazole 1-beta-D-ribofuranoside (DRB) to measure RNAPII transcriptional elongation rates (Singh and Padgett 2009) . DRB inhibits P-TEFbdependent phosphorylation of the transcription elongation factor Spt5 and of Serine 2 Maslon et al. 7 in the carboxy-terminal domain (CTD) of RNAPII. Thus, newly initiated RNAPII cannot progress to the elongation phase; however, upon DRB removal, all initiated polymerases are released and the appearance of selected intron-exon junctions can be monitored by qRT-PCR in a time-dependent manner. We monitored how transcription proceeded through the Utrophin and Itpr1 genes, following DRB removal.
Transcription over the first exon-intron junctions did not differ between the wild-type (WT) and mutant cell lines (Supplementary Fig. 3a , Exon 1-Intron 1 panel).
However, appreciable pre-mRNA levels at the more downstream exon-intron junctions were detected earlier in WT than in slow/slow cells. For example, the appearance of an exon-intron junction 133kb downstream from the Itpr1 transcription start site was detected at 40 min post-DRB release for the WT, as compared to 90 min for the mutant RNAPII ( Supplementary Fig. 3A , Exon 5-Intron 5 panel). An overall mean elongation rate across Utrophin and ITPR1 was estimated to be 5.6 and 3.3 kb/min, respectively in WT cells, as compared to 1 and 1.5 kb/min in slow/slow cells.
We also measured overall transcription using a reversible DRB block followed by incubation with medium containing tritiated (3H)-Uridine. Time-resolved accumulation of newly made RNA, as measured by the incorporation of 3H-Uridine, was attenuated in slow/slow in comparison to WT ESCs (Supplementary Fig. 3b ).
We also found that nuclear extracts isolated from slow/slow cells were less efficient in driving the production of a run-off transcript from the artificial DNA template (Supplementary Fig. 3c ). These results are in agreement with the previous observation that the R749H mutation in RNAPII leads to decrease in the transcription elongation rate in vitro (Boireau et al. 2007 ) and that the elongation rate positively correlates with expression levels (Danko et al. 2013; Jonkers et al. 2014 ).
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We analyzed RNAPII elongation rates genome-wide using metabolic labeling of newly transcribed RNAs by the uridine analogue, 4-thiouridine (4sU) (Rädle et al. 2013; Fuchs et al. 2014) . Transcription was arrested with DRB for 4 hours, following DRB removal, cells were allowed to transcribe for 5 and 15 mins. To label the newly transcribed RNA, cells were pulsed with 4sU for the last 10 min of each time point (Fig. 3a) . Cells not released from transcriptional block ("0 min") were also labeled with 4sU. Following biotinylation and purification, 4sU-labeled RNAs was subjected to deep sequencing. At time "0 min" the vast majority of reads were observed over a narrow area near the promoter (Fig. 3b, black line, Supplementary Fig. 4a , top panel). As time progresses, the reads from nascent RNA are observed further into the gene bodies, referred to as the transcription "wave front" progression ( Supplementary Fig. 4a , wave front progression in Notch1). On average, we observed that in WT cells, RNAPII had progressed 11 kb into the gene at 5 min and up to 35.8 kb at 15 min after DRB removal. By contrast, in slow/slow cells the transcription wave-fronts reached 8.6 kb and 26.7 kb at 5 and 15 min time points, respectively ( Supplementary Fig. 4b and Fig. 3b) . Genome-wide, we observed an average elongation rate of 2,450 bases/min in WT cells, but reduced rates of 1,780 bases/min in slow/slow cells (Fig. 3b,d) . The density plot of elongation rates demonstrates that the dynamic range of transcription rates is narrower in slow RNAPII cells, whilst in WT cells it is bimodal revealing a population of RNAPII transcribing at higher rates (Fig. 3c) . Indeed, most genes have a lower elongation rate in slow/slow cells in comparison to wild-type cells (e.g. Ern1 is transcribed at 4.2kb/min and 1.9kb/min, in WT and slow/slow cells, respectively). Interestingly, there are examples of genes that are transcribed faster in slow/slow cells. A slower elongation rate might translate to a longer residence time, allowing more time for Maslon et al. 9 positive factors to bind and/or stimulate RNAPII and consequently lead to higher transcription rates for these genes. Finally, there is a positive correlation between elongation rate and expression levels (Supplemental Fig. S4C ), indicating that on average, highly expressed genes have faster elongation rates in agreement with previous reports (Jonkers et al. 2014; Danko et al. 2013) . Overall, these data validate previous results obtained in cultured cells transfected with an α-amanitin-resistant RNAPII harboring the C4 mutation (de la Mata et al. 2003; Fong et al. 2014) and confirm that the endogenous knock-in of a slow RNAPII mutation affects negatively the transcriptional elongation rate in mouse ESCs.
Role of transcriptional elongation during neural differentiation
To assess whether a differential transcription elongation rate affects ESC differentiation, we exploited an in vitro model of neuronal development. During embryonic development, different pathways control self-renewal and differentiation capacity of neural progenitors (Doe 2008; Aguirre et al. 2010; Faigle and Song 2013) .
We used a serum-free adherent monolayer culture protocol (Ying et al. 2003; Conti et al. 2005) , that generates multipotent Sox1 and nestin-positive neuronal progenitor cells (NPCs) (Fig. 4a) . The ESC-derived NPCs can then be used to generate neural stem cells (NSCs) by allowing these cells to form floating aggregates in epidermal/fibroblast growth factor 2 (EGF/FGF2)-containing medium that then outgrow a population of bipolar NSCs when plated in adherent conditions (Fig. 4a) .
The initial heterogeneity of NSC-containing cell population is reduced following a few passages. Alternatively, the ESC-derived NPCs can be differentiated into all three neural lineages. For example, when cultured adherently on poly-ornithine/laminin in media containing cAMP and ascorbic acid, NPCs differentiate into Tuj1+ immature neuronal cells and further into Map2-positive mature post-mitotic neurons.
We first attempted to differentiate WT ESCs and slow/slow ESCs into NPCs; however, we observed decreased proliferation or compromised differentiation potential of slow/slow cells. Nevertheless, we found that both wild-type and slow/slow cells generated Sox1 and nestin-positive NPCs (Fig. 4b) . Neuronal differentiation becomes evident at around the fifth day of adherent monoculture, and indeed following 7 days we observed Tuj1-positive cells in both WT and slow/slow cells. Overall, we conclude that slow allele is compatible with in vitro differentiation into NPCs. We next tested if we could generate NSCs from slow/slow ESC-derived NPCs. Interestingly, we found that despite obtaining neural aggregates, slow/slow NSCs could not be maintained in EGF/FGF2 proliferating conditions ( Fig. 4d and data not shown). Instead, following a few passages we noted the appearance of flattened differentiated cells in the slow/slow cultures, and subsequently we observed overwhelming cellular death. Strikingly, amongst some of the remaining nestinpositive slow/slow cells, we observed promiscuous differentiation to Tuj1+ cells (Fig.   4d) . These results suggest that the balance between the self-renewing cell state and differentiation is perturbed in slow/slow NSCs.
Although the slow RNAPII allele appears to impair the maintenance of NSCs, the presence of differentiated Tuj1 neurons in both the monolayer (Fig. 4b) and the NSC cultures ( Fig. 4d) suggests that a slow transcriptional elongation rate does not impair neuronal differentiation per se. Indeed, WT and slow/slow ESCs generated PSA-NCAM-positive neuronal precursors with similar efficiencies in this protocol (data not shown) and differentiated into immature Tuj1-positive and mature Map2-positive neurons (Fig. 4e) . Whereas we observed a robust expression of the synaptic marker (Syn1) in WT neurons, it seemed greatly reduced in slow/slow neurons (Fig. 4e, right panel). Overall these data show that the slow mutation in RNAPII causes problems in the maintenance/self-renewal of NSCs and appears not to interfere with neuronal differentiation per se; however, it also indicates that homozygous slow neurons might be functionally or developmentally different than WT neurons.
Transcriptional elongation rate influences AS decisions in ESCs and during neural differentiation
Next, we investigated AS changes by RNA sequencing (RNA-seq) analysis of poly(A)+ RNA isolated from pluripotent ESCs, NPCs, PSA-NCAM+ cells and neurons (Fig. 5a, Supplementary Table 1) . We identified 80, 171, 50 and 424 events of enhanced exon inclusion, comprising cassette exons and microexons, in slow/slow ESCs, NPCs, PSA-NCAM+ cells and neurons, respectively, as compared to their WT counterparts. We also observed that whereas exon events did not show a bias towards increased inclusion in slow/slow ESCs or NPC cells when compared to WT cells, there was some tendency for an increased exon inclusion in slow/slow neurons (60% of alternative events are more included) (Fig. 5a) . By contrast, we found that exon skipping was enhanced relative to inclusion by the slow RNAPII mutant, with 94, 524 and 148 skipped cassette exons and microexons detected in ESCs, NPCs and PSA-NCAM+ cells, respectively. This is compatible with the current models of kinetic coupling, where a slow RNAPII can lead to enhanced exon inclusion if the AS event depends on the recruitment of positive regulators, or to exon skipping, if splicing inhibitors are recruited (Dujardin et al. 2014) . Indeed, as an example of the latter, RNA maps produced for RNA-binding proteins (CISBP-RNA IUPAC binding motifs (Ray et al. 2013) ) revealed that introns downstream of downregulated exons in neurons are enriched for Nova and Fox1 binding site ( Supplementary Fig. 5 ).
Binding of these factors downstream of alternative exons, has been previously shown to increase their skipping (Ule et al. 2006; Licatalosi et al. 2008; Zhang et al. 2008 ).
Importantly, the extent of splicing changes was much more pronounced in NPCs and fully differentiated neurons in comparison to ESCs (174 cassette exon and microexon events changing in slow/slow ESCs as compared to 695 or 704 cassette exons and microexons changes observed in slow/slow NPCs and neurons, respectively, Fig. 5a ). These results underscore the predominant role of kinetic coupling as differentiation progress. A possible explanation for this observation is related to changes in chromatin structure during cell differentiation. Chromatin is reported to be more open and accessible in pluripotent ESCs (Gaspar-Maia et al. 2011 ). This differential chromatin organization will likely have a direct influence in the elongation rate of RNAPII (Selth et al. 2010; Naftelberg et al. 2015) . Thus, a slow elongating RNAPII will exacerbate the dependence of AS on kinetic coupling upon cellular differentiation, as it is further hindered by the compactness of chromatin. Not only, did we observe an elevated number of affected exons in slow/slow neurons in comparison to slow/slow ESC, but also the number of splicing changes increases during differentiation to neurons, with 1,365 AS events detected in WT cells upon differentiation, whereas this number increases to 2,252 exons in slow/slow cells (Supplementary Table 1 ). We examined the properties of elongation-rate sensitive exons, namely 5' and 3' splice sites strength, as well as the length of flanking introns and alternative exons (Yeo and Burge 2004; Corvelo et al. 2010; Corioni et al. 2011) ( Fig. 5c and Supplementary Tables 2-5). We noted that exons more included in slow/slow ESCs had longer flanking introns (median of 2,335 and 1,546 bases in included and not-affected exons, respectively). Consistent with the 'window-of-opportunity' model of kinetic coupling, these longer introns could contribute to a time delay significant enough to promote recognition and splicing of suboptimal exons in nascent transcripts. By contrast, exons skipped in slow/slow neurons were on average shorter and had longer introns, whereas included exons were on average flanked by shorter introns. The features that we identified in neuron-specific exons are similar to those found in exons excluded by a slow RNAPII in 293T cells (Fong et al. 2014) . Table 6 ). We looked at whether the observed changes in AS are coupled to changes in the expression of corresponding genes. Notably, the differential splicing observed in the presence of a slow elongating RNAPII is generally not driven by differential gene expression ( Supplementary Fig. 6 ). The exception is some cases of intron retention, where negative correlation with the expression might reflect frequent coupling of intron retention to NMD (Supplementary Fig. 6 ). We investigated whether the splicing signature in slow/slow cells was a result of perturbations in the elongation rate or was indirect and caused by changes in expression of splicing factors and/or RNA-binding proteins (RBPs). We used available datasets from experimental perturbations of some of differentially expressed splicing factors ( Supplementary   Fig. 7a ) and noticed some overlap with the splicing events found in slow/slow cells ( Supplementary Fig. 7b ). They are not, however, sufficient to explain all the changes Maslon et al.
14 that we observe in slow/slow cells, indicating that most changes in AS events can be attributed to a slower elongation rate.
Slow transcription elongation perturbs expression of long synaptic genes
To understand whether slow RNAPII-responsive genes are functionally linked, and whether certain pathways were particularly sensitive to kinetic coupling, we searched for significant enrichment of specific Gene Ontology (GO) terms in all stages of differentiation ( Supplementary Fig. 8 and data not shown). We first noted that genes upregulated in NPCs are involved in neuronal functions ( Supplementary Fig. 8A ), which might explain the phenotypes observed in slow/slow NSCs (Fig. 4) . Indeed, we confirmed upregulation of Nr2f1, Nr6a1, Ascl1 and Crabp2 genes. Their overexpression has been shown to suppress proliferation of progenitor cells, induce neurogenesis and neuronal maturation (Gkikas et al. 2017; Chanda et al. 2014 ). Fig. 9 ) and could explain the premature differentiation observed in slow/slow NSCs. In parallel, we observed that the EGF receptor (EGFR) was two-fold downregulated in slow/slow NPCs (Supplementary Table 6 ). As EGF withdrawal causes massive cell death and premature differentiation of NSCs (Conti et al. 2005) , decreased expression of EGFR in slow/slow NSCs could contribute to the observed lack of their self-renewal in EGF/FGF2 proliferating conditions. Enrichment Map visualization of gene-sets enriched amongst downregulated and AS genes in slow/slow neurons revealed that they are involved in synapse formation and synaptic signaling (Fig. 7a, c and Supplementary Fig. 8b-d) . Indeed, genes downregulated in slow/slow neurons encoded proteins involved in the entire life cycle of synaptic vesicles. Amongst them were: Syn1 and Syn2, which tether the vesicle to the actin cytoskeleton (Thomas et al. 1988 ), Snap25, Stx1b, Stxbp1, Syt1 proteins that are involved in synaptic vesicle fusion and recycling; as well as neurexins (NRXN1 and NRXN2) and contactin-associated proteins (CNTNAP2 and CNTNAP3) that form the synaptic scaffolding system and are involved in trans-synaptic communication.
(Supplementary
The largest differences observed in AS in slow/slow neurons involved skipping of exons that have been previously shown to be included in neurons, and conversely most exons that are included in slow/slow neurons, are normally skipped in neurons (Fig. 7b) . Moreover, and similarly to downregulated genes, these alternative events involved proteins that are important for synaptic signaling (Fig. 7a, c, Table 1 and Supplementary Table 7) . For example, we observed increased skipping of the alternative exon in Scrib, a gene encoding a protein involved in neurotransmitter release ( Fig. 5b and 7c) . We also confirmed differential splicing of Apbb2, a protein involved in synaptic vesicle loading ( Fig. 5b and 7c) . We noted altered splicing amongst members of neurexins, synaptic receptors that undergo an extensive combinatorial use of AS to provide molecular diversity required for the functional differentiation of synapses (Schreiner et al. 2014) . (Supplementary Table   1 ). Finally, we observed, AS events in proteins involved in the synaptic vesicle cycle, including both pre-synaptic and post-synaptic space, amongst them Stx4A, Syn1, Synj1, Stx3 and many others, some of them resulting in premature termination codons, others changing domain structures or affecting ion transfer, hence all likely contributing to the function of the synapse (Fig. 7c and Table 1 ).
Interestingly, we noticed that those genes that are preferentially downregulated and/or alternatively spliced in slow/slow neurons, tend to be significantly longer than those that were not affected or that are upregulated. These include genes encoding proteins present in the synaptic network (Fig. 7d) . By contrast, we found no significant change in the average gene length between downregulated genes and all expressed genes in ESCs and PSA-NCAM+ or NPCs (Fig. 7d and data not shown) .
Notably, a slow transcriptional elongation rate reduced expression of nearly all long genes in neurons, with the percentage of downregulated genes in slow/slow neurons progressively increasing from around 40% for 10 kb genes to over 80% for extremely long genes (Fig. 7e) . Some examples of such genes include Cntnap2 (2.25 Mb) and Nrxn1 (1.05 Mb) (Supplementary Table 6 ). Similarly, AS also affected longer premRNAs. From this we speculate that an optimal elongation rate is important to sustain transcription and splicing of particularly long transcripts that are required for neuronal function. Indeed, recent reports propose that long genes require special mechanisms to specifically maintain long-distance transcription. As an example, the neuronal RBP Sfpq (proline/glutamine-rich), has been shown to be a critical factor for maintaining transcriptional elongation of long genes (Patton et al. 1993; Takeuchi et al. 2018 ).
Thus, both downregulated as well as preferentially alternatively spliced genes in slow/slow neurons converged onto long genes that are involved in synaptic function.
Candidate genes involved in neurodevelopmental diseases encode synapse proteins and are exceptionally long (Bourgeron 2015) . Therefore, we further analyzed the overlap of the genes downregulated and differentially spliced in slow/slow neurons with available datasets for brain disease, including causative genes for autism (SFARI) and schizophrenia. We noted that these genes significantly overlapped with those linked to neurological disorders, including ASD disease (Supplementary Table   8) . From these experiments, we conclude that a reduced transcriptional elongation rate preferentially affects the expression and AS of long synaptic genes.
In summary, the development of a genetic system based on knock-in for a slow RNAPII mutation in mouse ESCs unequivocally established that an appropriate RNAPII elongation rate is essential for proper mouse development and for gene expression and its kinetic coupling with AS. Our results provide compelling evidence that transcription elongation rates have a regulatory role in the expression of genes and the regulation of their AS patterns during development.
Discussion
We observed that a slow transcriptional elongation rate resulted in early embryonic lethality even in heterozygosity (Fig. 2) . It is possible that a slow elongation rate cannot sustain the high levels of mRNA production required at early stages of development (Koh et al. 2015; Percharde et al. 2017) . Similarly, loss of self-renewal in slow/slow NSCs could be related to the inability of cells harboring a slow RNAPII to maintain the required levels of transcriptional output. Initial stages of mouse embryonic development display a great range of cell cycle duration, from up to 20 hours for the first cell division to 2-3 hours cell cycles during gastrulation (Artus et al. 2006) or 8 hours during initial stages of murine neurogenesis (Takahashi et al. 1995) .
Thus, a reduced elongation rate in slow/slow mutant embryos might not allow efficient transcription or might delay expression of some crucial mRNAs that need to be expressed in these fast dividing cells. Whereas in mice both the homozygous and heterozygous slow mutation result in embryonic lethality (Fig. 2) , the C4 mutation in Drosophila is tolerated in heterozygosity where the flies present a mutant phenotype called "Ubx effect" that resembles the one seen in flies haploinsufficient for the Ubx protein. This was attributed to Ubx missplicing as it is one of the few Drosophila genes with an extremely long intron (50 kb)(de la Mata et al. 2003) . This is in agreement with results presented here showing that mouse genes with long introns are preferentially affected by a slow RNAPII in ESC-differentiated neurons.
The slow RNAPII mutant used in this study is less efficient at dealing with naturally occurring pause sites in vivo (de la Mata et al. 2003; Fong et al. 2014) . We found that the impact of RNAPII elongation rate on AS is predominant in ESCs-differentiated NPCs and neurons. This is likely caused by distinct chromatin environment between pluripotent and differentiated cells having a differential impact on RNAPII transcriptional elongation rate. While chromatin is quite dispersed in E3.5, heterochromatin foci appear in E5.5, which corresponds to the epiblast stage following embryo implantation (Ahmed et al. 2010) . Indeed, despite the conflicting literature regarding deposition of histone marks throughout differentiation (Azuara et al. 2006; Wen et al. 2009; Lienert et al. 2011) , a large body of evidence suggests that chromatin undergoes dynamic changes during differentiation leading to a more compact environment in the differentiated state. Various mechanisms might promote the switch from a more open to a more close chromatin during cell differentiation, including an increase in repressive histone marks, a local change in nucleosome occupancy, or a general increase in histones levels (Fiszbein et al. 2016; Gavin et al. 2017; Yoon et al. 2018) . Indeed, the nuclei of ESCs macroscopically appears to contain less condensed chromatin, whereas well-defined foci of compact heterochromatin become evident in ESCs-derived NPCs (Meshorer et al. 2006 ).
Indeed, chromatin structure can become a major impediment to transcriptional elongation and histone modifications can directly affect the nucleosomes, by either loosening or tightening DNA binding around them (Veloso et al. 2014; Jonkers and Lis 2015) . Moreover, exons have a negative effect on RNAPII elongation rate, which could be associated with exonic features, such as a higher CG content, and exonspecific histone marks (H3K36me3 and H3K4me1) (Jonkers et al. 2014 ). An example of a crosstalk between the chromatin environment an AS has been shown in the case of exon18 in the neural cell adhesion molecule (NCAM), where membrane depolarization of neuronal cells induces a local H3K9 hyperacetylation, resulting in exon skipping ). Conversely, inducing a more compact chromatin state by transfection of siRNAs targeting the intron downstream of an alternative exon, promotes H3K9 and H3K27 methylation, HP1 recruitment, in turn leading to local roadblocks for RNAPII elongation rate and increased kinetic coupling ). We speculate that the specific changes in chromatin structure during differentiation might create natural "roadblocks"to elongating RNAPII, which is further enhanced in slow RNAPII-expressing cells leading to increased kinetic coupling observed in NPCs and neurons derived from slow/slow cells.
Slow RNAPII leads to specific downregulation of longer genes in neurons.
Dysregulation of the expression of these long genes might represent a mechanism underlying neurodegenerative and psychiatric disorders (Gabel et al. 2015; King et al. 2013 ). For example, loss of FUS/TLS and TDP43, genes linked to ALS, preferentially affects splicing of long pre-mRNAs (Lagier-Tourenne et al. 2012). The neuronal RBP SFPQ, which is required to sustain long-distance transcription elongation for longer genes (Takeuchi et al. 2018) , has a role in neurodegenerative diseases, including ALS, ASD and Frontotemporal lobar degeneration (FTLD). The differentially expressed and alternatively spliced pre-mRNAs in neurons, are involved in synapse signaling, neurite outgrowth and axonal guidance (Fig. 7) . We speculate that misregulation of RNAPII elongation rate could have detrimental implication in neurodevelopment, preferentially affecting the expression and/or splicing of synaptic proteins, which are encoded by particularly long genes (Fig. 7) . Indeed mutations in genes involved in synaptic signaling lead to neurodevelopmental diseases, including Autism spectrum disorder (ASD) (Bourgeron 2015) . Importantly, chromatin Maslon et al. 20 remodeling, transcription and splicing genes have been identified in genetics studies of de novo mutations in autistic patients (De Rubeis et al. 2014) . Physiological conditions that could alter RNAPII elongation or mutations disrupting elongation rate control might affect preferentially the nervous system, as these cells express particularly long genes. This could result not only in changes in transcription but also affect AS patterns via kinetic coupling. These observations highlight an essential role for an appropriate elongation rate in gene expression and splicing regulation during neural development and suggest that its misregulation could underlie some neurological disorders.
In conclusion, we show that a slow elongation rate affects gene expression and AS, consistent with the coupling of transcription with splicing. This kinetic control of AS is more strongly affected as differentiation progress. Most notably, we identify elongation rate control as a major mechanism to sustain transcription and splicing of long neuronal genes involved in synapse signaling. This study provides a compelling evidence that transcription elongation rates have a regulatory role in the expression of genes and the regulation of their AS patterns during development.
Methods
Cell lines generation. BAC containing the Polr2a locus was used to introduce the R749H mutation into exon 14. To this end two sets of primers were used that have 50bp homology arms to target the Pol2 exon 14 and either regions to hybridize to galK selection cassette or complementary regions containing the R749H point mutation to hybridize to each other. The galK selection cassette was amplified from pGalK and 1.3kb product was electroporated into E.coli strain containing BAC clone bMQ420i24 and recombination was induced by heat shock. PCR was set up with second pair of primers and the resulting 132bp primer dimer was recombined with
Gal modified BAC clone. Gal-modification introduces EcoRI and BamHI restriction sites into exon 14 of Polr2a along with R749H. 10.4 kb region of the Polr2a locus was retrieved from the Gal-modified Polr2a BAC clone by gap repair. Mini-targeting cassette was then generated to recombine Frt-flanked neomycin cassette into intron 12 of Polr2 locus. This generated the Pol2ra constitutive targeting vector. The resulting targeting vectors were linearized and introduced into E14 ESCs by electroporation.
Genomic DNAs from were screened for homologous recombination by PCR and Southern blot.
Cell differentiation. ESCs were cultured under feeder-free conditions in GMEM medium supplemented with 10% foetal calf serum, NEAA, β-mercaptoethanol, sodium pyruvate, L-glutamine and 100 U/ml recombinant leukaemia inhibitory factor (LIF) on gelatin-coated tissue culture plastic. Before differentiation, cells were freshly defrosted in standard medium and then passaged for 2 passages in 2i medium (1:1
Neurobasal and DMEM/F12, supplemented with 0.5X N2, 0.5x B27, 0.05% BSA, 1μM 0325901, 3μM CHIR99021, 2mM L-glutamine, 0.15mM monothioglycerol, 100U/ml LIF).
Neuroectodermal specification. One day prior to induction of differentiation cells were seeded at high density in 2i medium. The following day, cells were detached using accutase, resuspended in N2B27 media (1:1 Neurobasal and DMEM/F12, supplemented with 0.5X N2, 0.5x B27, 0.1 mM β-mercaptoethanol, 0.2 mM Lglutamine), counted and plated at the appropriated density onto either 15 cm plates or 6 well plates that have been coated with a 0.1% gelatin solution. Culture medium was changed every second day. The differentiation potential is greatly influenced by the initial plating density and was previously established to be optimal at approximately 10,000 cells per cm 2 , which is what we observed with the differentiation of WT ESCs.
On the contrary, we observed increased cell death at plating densities below 30,000 cells per cm 2 for slow/slow cells, suggesting decreased proliferation or compromised differentiation potential of these cells.
Isolation of PSA-NCAM+ cells.
For neuronal precursor differentiation, cells were differentiated as above for 10 days, detached using accutase and PSA-NCAM+ cells were purified using PSA-NCAM beads (Miltenyi).
Deriving NS cells. For derivation of neural stem cells at day 7 of differentiation,
cultures were detached using accutase, 2-3 x 10 6 cells were re-plated into an uncoated T75 flask in NS expansion media, comprising DMEM/F12 medium supplemented with 2mM L-glutamine, 0.5x N2, B27, glucose, BSA, Hepes and 10ng/ml of both mouse EGF (Peprotech) and human FGF-2 (Peprotech). Within 2-3 days, thousands of cell aggregates formed in suspension culture and were harvested by centrifugation at 700 rpm for 1 minute. They were then re-plated onto a laminin coated T75 flask.
After few days, cell aggregates attached to the flask and outgrew with NS cell.
Differentiation to neurons.
For neuronal generation and maturation at day 7 of differentiation, cultures were detached using accutase, replated onto poly-lornithine/laminin (100 μg/ml and 10 μg/ml, respectively, Sigma-Aldrich) coated surfaces at 1.5-2 x 10 4 cells/ cm 2 in N2B27 medium containing 0.2mM ascorbic acid and 0.25 mM cAMP. Cells were grown for the additional 7 days, with 80% media exchange every second day.
Nascent transcription assays.
Elongation rate experiments were carried out as isopropanol. Following one wash in 80% ethanol, the RNA pellet was left to dry and resuspended in 100 μl RNase-free water. Biotinylated RNA was purified using μMacs Streptavidin kit. Specifically, 100 μl of beads per 100 μg of RNA was incubated with rotation for 15 min, and then washed three times with washing buffer (100 mM Tris pH 7.5, 10 mM EDTA, 1 M NaCl, 0.1% Tween20) at 65°C, followed by three washes at room temperature. RNA was eluted twice using 100 mM DTT and recovered using RNeasy MinElute Cleanup column (Qiagen) according to instructions. cDNA libraries Maslon et al. 25 were prepared using NEB Next Ultra Directional RNA Library Prep Kit according to the manufacturer's instructions. Libraries were pooled and sequenced on an Illumina
HiSeq 4000 system. All reads were aligned to the mouse reference genome (mm10) using bowtie 2 aligner (Langmead et al. 2009 ) and only those reads that mapped uniquely to the genome, but not to rRNA, were considered. A genome-wide binned profile of the nascent RNA and the transcription wave end were determined using previously developed methods and published software (Fuchs et al. 2015 (Fuchs et al. , 2014 .
RNA-Seq analysis. RNA-Seq libraries were generated from Poly(A) + mRNA and sequenced using the Illumina Hi-Seq 2500 or 4000 machine to generate 125 bases or 75 bases, paired end reads, respectively. Reads were mapped to the mouse (mm9) genome. AS analysis of RNA-Seq data was performed with vast-tools version 1 (Tapial et al. 2017) . From the primary output, events with poor coverage or junction balance were filtered out (vast-tools quality score 3 other than SOK/OK/LOW for cassette exon [CE] , microexon [MIC] , and alternative 5´ or 3´ splice site [Alt5/3] events or coverage less than 15 reads for intron retention [IR] events; score 4 other than OK/B1 for CE and MIC events and score 5 of less than 0.05 for IR events).
Differential AS was scored using vast-tool's diff module requiring p(|dPSI| > 0) > 0.05 and a point estimate of |dPSI| > 10. Gene expression was analysed based on raw read counts per gene from vast-tools using the glm stream of the R package edgeR. Genes with an FDR < 0.05 were considered differentially expressed.
Analysis of splicing factors regulation of AS.
We used available RNA-seq data from splicing factor knockdowns or knockouts (MBNL2 in mouse hippocampi (Goodwin et al. 2015; Charizanis et al. 2012) , MBNL3 (Poulos et al. 2013) Srrm4/nSR100 and Ptbp1 in mouse N2A cells ), Ptbp2 in mouse brain (Li et al. 2014) , HNRNPA2B1 in mouse spinal cord (Martinez et al. 2016 ), KHDRSB3 (Ehrmann et al. 2013 ), Nova1 (Zhang et al. 2010; Ule et al. 2006 ) and Rbfox1 in mouse whole brain (Lovci et al. 2013) ) and their associated controls, to identify AS exons whose inclusion levels are affected by experimental manipulation of the expression of the splicing factors.
In vitro transcription assay. Nuclear extracts were prepared according as previously described (Folco et al. 2012) . A DNA construct, containing CMV promoter and encoding β−globin was linearized by restriction digest. In vitro transcription reactions were performed at 30°C in 25 μl reaction mixtures containing 375 ng DNA template, 1 μl 32P-UTP, 10 μl ESCs nuclear extract, 10 mM ATP, CTP, GTP, 0.4 mM UTP, 3.2 mM MgCl2. Following indicated time, proteinase K was added to stop transcription. RNA was extracted and run on denaturing polyacrylamide gel and detected by phosphoimager.
CRISPR. The 20nt Guide RNA sequences required for Cas9 specificity were chosen using the online tool at http://crispr.mit.edu/. gRNAs were ordered as custom single stranded DNA oligos (Sigma) with the appropriate reverse sequence and resuspended to 100 μM in dH2O. Complementary oligos were annealed at 100 mM in 10x T4
DNA Ligase Buffer (NEB) by heating to 95C for 2 minutes in a heat block which was subsequently allowed to cool slowly to room temperature. Successful annealing was confirmed by gel electrophoresis and introduced into either the PX461 cloning vectors using Bbs1 (NEB) restriction cloning. For blastocyst injections, Cas9 nickase RNA was used in combination with in vitro transcribed gRNAs and a DNA oligo repair template. gRNA sequence from the PX461 was amplified using oligos Maslon et al. 27 complementary to guide sequence and containing (Sigma) the T7 promoter sequence at the 5' end of the forward primer. PCR was performed using GoTaq 2x Green Master Mix in a 50 ml reaction volume with 200 ng template DNA. PCR thermal programme used was as follows: initial denaturing 95ºC 2mins, then 35x cycles of:
second denaturing 95ºC 30 sec, annealing 56ºC 30 sec, extension 72ºC 20 sec, before final extension 72ºC 5 min. PCR product was purified using the PCR purification kit (Qiagen) as per the manufacturer's instructions. A second PCR amplification step was performed using the entire elute from this cleanup of the first PCR reaction using the same thermal cycling profile. RNA synthesis was carried out from the amplified DNA using the MEGAscript T7 Transcription kit (Invitrogen, AM1334) following the manufacturer's instructions. The entire purified PCR product (approximately 1μg) was used with incubation at 37ºC overnight. Transcribed RNA was purified using the RNAeasy kit (Qiagen) following the "cleanup" part of the manufacturer's protocol.
RNA was quantified using the Nanodrop, with dilution as appropriate. Injection mixes were prepared in a total volume of 20 μl as follows: Cas9 RNA (TriLink BioTechnologies), 50ng/μl, guide RNAs, 25ng/μl, repair template oligo, 75ng/μl.
Multiple oligo repair templates were tried, with silent restriction sites incorporated.
Mixes were centrifuged at maximum speed, 4ºC for 30 mins to remove impurities, before the supernatant was transferred to a fresh tube.
RNA isolation and RT-QPCR. RNA was isolated using TRIzol or RNAeasy following the manufacturer's protocol. RNA was then treated with Dnase (Ambion) and transcribed to cDNA using First-Strand Synthesis System from Roche. This was followed by SybrGreen detection system (Lightcycler 2x SybrGreen Mix, Roche). by GSEA for GO_BP and KEGG pathways. Gorilla, Metascape or g:profiler was
employed for the analysis of GO enrichment during neuronal differentiation. 
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